You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adult T-Cell Leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Adult T-Cell Leukemia/Lymphoma, Lymphatic Diseases Trial in Hollywood, Boston, Chapel Hill (Brentuximab Vedotin, CHEP)

Active, not recruiting
  • Lymphoma
  • +2 more
  • Brentuximab Vedotin
  • CHEP
  • Hollywood, Florida
  • +3 more
Nov 30, 2022

Adult T-Cell Lymphoma/Leukemia, Sezary Syndrome, Mycosis Fungoides Trial run by the NCI (Recombinant human Interleukin-15

Completed
Has Results
  • Adult T-Cell Lymphoma/Leukemia
  • +2 more
  • Recombinant human Interleukin-15 (rhIL-15)
  • Mogamulizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 9, 2022

Recurrent Adult T-Cell Leukemia/Lymphoma, Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Refractory Adult T-Cell

Recruiting
  • Recurrent Adult T-Cell Leukemia/Lymphoma
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Nov 18, 2022

T-Cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Angioimmunoblastic T-cell Lymphoma Trial in Saint Louis (WU-CART-007)

Not yet recruiting
  • T-Cell Non-Hodgkin Lymphoma
  • +14 more
  • WU-CART-007
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 17, 2023

T-Cell Lymphoma Relapsed, Adult T-Cell Leukemia (ATL), Peripheral T-Cell Lymphoma (PTCL) Trial run by the NCI (IL-15 plus,

Completed
Has Results
  • T-Cell Lymphoma Relapsed
  • +4 more
  • IL-15 plus
  • alemtuzumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 27, 2022

Acute Adult T-Cell Leukemia/Lymphoma, Adult T-Cell Leukemia/Lymphoma, Chronic Adult T-Cell Leukemia/Lymphoma Trial in United

Recruiting
  • Acute Adult T-Cell Leukemia/Lymphoma
  • +3 more
  • Atlanta, Georgia
  • +13 more
Jan 26, 2023

Survival of Adult T-cell Leukemia / Lymphoma and Patients

Recruiting
  • Lymphoproliferation Induced by HTLV-1
  • +2 more
    • Paris, France
      Hôpital Necker Enfants Malades
    Sep 26, 2022

    T Cell Leukemia, Adult, Leukemia, Adult T-Cell, T Cell Leukemia, HTLV I Associated Trial run by the NCI (Ruxolitinib,

    Completed
    • T Cell Leukemia, Adult
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jan 26, 2022

    Adult T-Cell Leukemia (ATL) Trial run by the NCI (LMB-2, Fludarabine, Cyclophosphamide)

    Active, not recruiting
    Has Results
    • Adult T-Cell Leukemia (ATL)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jan 13, 2022

    Adult T-cell Leukemia-Lymphoma, ATLL Trial in Miami (Belinostat, Zidovudine, Interferon-Alfa-2b)

    Recruiting
    • Adult T-cell Leukemia-Lymphoma
    • ATLL
    • Miami, Florida
      University of Miami
    Jan 24, 2022

    Refractory Leukemia, Relapsed Leukemia, Acute Myelogenous Leukemia Trial in Miami (STING-Dependent Activators (STAVs) Loaded

    Not yet recruiting
    • Refractory Leukemia
    • +4 more
    • STING-Dependent Activators (STAVs) Loaded Autologous Leukemic Cells
    • Dendritic Cell Vaccine
    • Miami, Florida
      University of Miami
    Jan 23, 2023

    Adult T-cell Leukemia/Lymphoma, Extranodal NK-/T-cell Lymphoma, Nasal Type, Enteropathy-Associated T-Cell Lymphoma Trial run by

    Not yet recruiting
    • Adult T-cell Leukemia/Lymphoma
    • +4 more
    • CC-486 (5-azacitidine)
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 17, 2022

    T Lymphoblastic Leukemia/Lymphoma Trial in Shenzhen (CD7 CAR-T cells)

    Recruiting
    • T Lymphoblastic Leukemia/Lymphoma
    • CD7 CAR-T cells
    • Shenzhen, Guangdong, China
      Li Yu
    Nov 11, 2022

    Determining the Mechanisms of Loss of CAR T Cell Persistence

    Not yet recruiting
    • Acute Lymphoblastic Leukemia With Failed Remission
    • +4 more
      • (no location specified)
      Mar 29, 2023

      Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

      Active, not recruiting
      • Adult Lymphocyte Depletion Hodgkin Lymphoma
      • +16 more
      • 6,8-bis(benzylthio)octanoic acid
      • bendamustine hydrochloride
      • Winston-Salem, North Carolina
      • +1 more
      Apr 8, 2022

      T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

      Recruiting
      • T-cell Lymphoma
      • +30 more
      • Optional Blood Sample
      • Optional Nail Sample
      • Duarte, California
      • +25 more
      Jul 28, 2023

      T-Acute Lymphoblastic Leukemia, Adult T Lymphoblastic Lymphoma Trial in United States (BL-8040, Nelarabine)

      Terminated
      • T-Acute Lymphoblastic Leukemia
      • Adult T Lymphoblastic Lymphoma
      • Saint Louis, Missouri
      • +1 more
      Jan 18, 2023

      Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)

      Active, not recruiting
      • Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)
      • Yamagata, Japan
        Yamagata University Hospital
      Feb 21, 2022

      Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

      Active, not recruiting
      • Accelerated Phase Chronic Myelogenous Leukemia
      • +125 more
      • tetanus-CMV fusion peptide vaccine
      • laboratory biomarker analysis
      • Duarte, California
        City of Hope Medical Center
      Feb 28, 2022

      T-cell Acute Lymphoblastic Leukemia, T-lymphoblastic Lymphoma Trial in Kunming (Target CD7 CAR-T cells)

      Withdrawn
      • T-cell Acute Lymphoblastic Leukemia
      • T-lymphoblastic Lymphoma
      • Target CD7 CAR-T cells
      • Kunming, Yunnan, China
        920th Hospital of Joint Logistics Support Force of People's Libe
      Nov 23, 2022

      Acute Lymphoblastic Leukemia, in Relapse, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Columbus

      Not yet recruiting
      • Acute Lymphoblastic Leukemia, in Relapse
      • +5 more
      • CD19 specific Chimeric Antigen Receptor T Cell
      • Columbus, Ohio
        Nationwide Children's Hospital
      Mar 9, 2023

      Adult T-cell Leukemia/Lymphoma Trial in Japan (Valemetostat Tosylate)

      Active, not recruiting
      • Adult T-cell Leukemia/Lymphoma
      • Valemetostat Tosylate
      • Nagoya-shi, Aichi, Japan
      • +23 more
      Jan 11, 2022

      B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

      Not yet recruiting
      • B-cell Non Hodgkin Lymphoma
      • Chronic Lymphocytic Leukemia
      • Cyclophosphamide injection
      • +2 more
      • Charleston, South Carolina
        Hollings Cancer Center at Medical University of South Carolina
      Jan 18, 2023

      B Acute Lymphoblastic Leukemia, Ph-Negative ALL, High Risk Acute Lymphoblastic Leukemia Trial (Azacitidine Injection,

      Not yet recruiting
      • B Acute Lymphoblastic Leukemia
      • +2 more
      • Azacitidine Injection
      • +2 more
      • (no location specified)
      Oct 15, 2023

      Leukemia, Lymphoblastic, Leukemia Trial in Houston (CB-103, Venetoclax)

      Not yet recruiting
      • Leukemia, Lymphoblastic
      • Leukemia
      • Houston, Texas
        MD Anderson Cancer Center
      Jul 19, 2022